Page last updated: 2024-10-26

domperidone and Dermatitis Medicamentosa

domperidone has been researched along with Dermatitis Medicamentosa in 2 studies

Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kiefer, S1
Hasdenteufel, F1
Jarlot-Chevaux, S1
Hosotte, M1
Tréchot, P1
Kanny, G1
Takahama, H1
Noto, S1

Other Studies

2 other studies available for domperidone and Dermatitis Medicamentosa

ArticleYear
[Immediate hypersensitivity reaction to phloroglucinol (Spasfon(®))].
    Therapie, 2016, Volume: 71, Issue:3

    Topics: Adolescent; Domperidone; Drug Combinations; Drug Eruptions; Gastrointestinal Agents; Humans; Hyperse

2016
A case of erythema type drug eruption due to domperidone.
    The Journal of dermatology, 2002, Volume: 29, Issue:6

    Topics: Adult; Domperidone; Dopamine Antagonists; Drug Eruptions; Humans; Male

2002